<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57473">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02357862</url>
  </required_header>
  <id_info>
    <org_study_id>MVR_TV</org_study_id>
    <nct_id>NCT02357862</nct_id>
  </id_info>
  <brief_title>Changes in the Tricuspid Valve Complex Induced by Mitral Valve Annuloplasty</brief_title>
  <official_title>Impact of Isolated Mitral Valve Annuloplasty on the Geometry and the Function of the Tricuspid Valve Complex</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the impact of isolated mitral valve annuloplasty on
      the geometry and the function of the tricuspid valve complex.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed pathogenesis of functional tricuspid regurgitation (TR) in mitral valve disease
      seems incomplete. Because both atrioventricular valves are closely connected to each other
      by means of the cardiac fibrous skeleton, the geometry of the tricuspid valve is likely to
      be distorted after ring-annuloplasty of the mitral valve. This could lead to the development
      of functional TR, or to an increase in TR severity. To test this hypothesis, a prospective
      study will be started in patients undergoing isolated mitral valve annuloplasty.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative geometric changes in tricuspid valve annulus (TA)</measure>
    <time_frame>day 0</time_frame>
    <description>Measurement of changes in 3D descriptors of the TA (e.g. changes from baseline in the TA area of the best-fit plane in cm^2, and changes from baseline in the height of each TA point to the TA best-fit plane in mm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tricuspid valve regurgitation severity</measure>
    <time_frame>5 years</time_frame>
    <description>Patients stratified in 2 groups depending of the absence or the presence of post-operative morphological changes in the tricuspid valve annulus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>5 years</time_frame>
    <description>Patients stratified in 2 groups depending of the absence or the presence of post-operative morphological changes in the tricuspid valve annulus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac mortality</measure>
    <time_frame>5 years</time_frame>
    <description>Patients stratified in 2 groups depending of the absence or the presence of post-operative morphological changes in the tricuspid valve annulus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of heart failure</measure>
    <time_frame>5 years</time_frame>
    <description>Patients stratified in 2 groups depending of the absence or the presence of post-operative morphological changes in the tricuspid valve annulus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization for heart failure</measure>
    <time_frame>5 years</time_frame>
    <description>Patients stratified in 2 groups depending of the absence or the presence of post-operative morphological changes in the tricuspid valve annulus</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tricuspid (Valve); Deformity</condition>
  <arm_group>
    <arm_group_label>Mitral Valve Annuloplasty</arm_group_label>
    <description>All eligible patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mitral Valve Annuloplasty</intervention_name>
    <description>Mitral valve annuloplasty by a rigid mitral ring, a semi-rigid ring, or a fully flexible band, at the surgeon's discretion</description>
    <arm_group_label>Mitral Valve Annuloplasty</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing minimally invasive, isolated mitral valve annuloplasty in the
        University Hospitals Leuven
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients 18 years of age or older undergoing minimally invasive, isolated mitral
             valve annuloplasty

        Exclusion Criteria:

          -  concomitant tricuspid valve surgery

          -  atrial fibrillation at the moment of surgery

          -  poor echocardiographic windows
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Werner Budts, M.D., PhD</last_name>
    <role>Study Director</role>
    <affiliation>KU Leuven - University of Leuven, Department of Cardiovascular Sciences, Division of Cardiology; University Hospitals Leuven, Department of Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Herijgers, M.D., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KU Leuven - University of Leuven, Department of Cardiovascular Sciences, Division of Clinical Cardiac Surgery; University Hospitals Leuven, Department of Cardiac Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frederik Helsen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>KU Leuven - University of Leuven, Department of Cardiovascular Sciences, Division of Cardiology; University Hospitals Leuven, Department of Cardiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frederik Helsen, M.D.</last_name>
    <phone>00-32-16-342292</phone>
    <email>frederik.helsen@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederik Helsen, M.D.</last_name>
      <phone>00-32-16-342292</phone>
      <email>frederik.helsen@uzleuven.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>July 22, 2015</lastchanged_date>
  <firstreceived_date>January 26, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Heart Diseases</keyword>
  <keyword>Heart Valve Diseases</keyword>
  <keyword>Mitral Valve Annuloplasty</keyword>
  <keyword>Tricuspid Valve Insufficiency</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
